Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: A double-blind randomized clinical trial

Addiction

Volumn 102, Issue 12, 2007, Pages 1947-1953

  Peles, Einat ^a   Hetzroni, Tal ^a   Bar Hamburger, Rachel ^b   Adelson, Miriam ^a   Schreiber, Shaul ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Israel Anti Drug Authority   (Israel)

Author keywords

Abuse; Benzodiazepine; Melatonin; Methadone maintenance treatment (MMT); Sleep; Withdrawal

Indexed keywords

BENZODIAZEPINE; CLONAZEPAM; MELATONIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; MAINTENANCE THERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MELATONIN; METHADONE; MIDDLE AGED; SLEEP; SLEEP DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 36348998533     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.02007.x     Document Type: Article

References (35)

1. Bleich A., Gelkopf M., Weizman T., Adelson M. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach. Israel J Psychiatry Relat Sci 2002 39 : 104 12.
2. Iguchi M. Y., Handelsman L., Bickel W. K., Griffiths R. R. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 1993 32 : 257 66.
3. Mullins M. E. First-degree atrioventricular block in alprazolam overdose reversed by flumazenil. J Pharm Pharmacol 1999 51 : 367 70.
4. Bleich A., Gelkopf M., Schmidt V., Hayward R., Bodner G., Adelson M. Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1-year prospective study in an Israeli clinic. Addiction 1999 94 : 1533 40.
5. Weizman T., Gelkopf M., Melamed Y., Adelson M., Bleich A. Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity. Aust NZ J Psychiatry 2003 37 : 458 63.
6. Trudeau D. L. Clonazepam prescribing patterns and abuse by methadone patients in a medical center setting. J Addict Dis 1994 13 : 99 107.
7. Schreiber S. Benzodiazepines - an update. Harefuah 1993 125 : 172 4.
8. Goodman and Gillman's. The Pharmacological Basis of Therapeutics, 11th edn. Online edition, part III. Drugs Acting on the Central Nervous System, chapter 16. Hypnotics and Sedatives. Available at: http://www.accessmedicine. com/resourceTOC.aspx?resourceID=28 (accessed 7 October 2006).
9. Illnerova H., Borbely A. A., Wirz-Justice A., Prasko J. Circadian rhythmicity: from basic science to clinical approach. Suppl Clin Neurophysiol 2000 53 : 339 47.
10. Reiter R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991 12 : 151 80.
11. Lewy A. J., Ahmed S., Jackson J. M., Sack R. L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992 9 : 380 92.
12. Sharma M., Palacios-Bois J., Schwartz G., Iskandar H., Thakur M., Quirion R. et al. Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 1989 25 : 305 19.
13. Haimov I., Laudon M., Zisapel N., Souroujon M., Nof D., Shlitner A. et al. Sleep disorders and melatonin rhythms in elderly people. BMJ 1994 309 : 167.
14. Brugger P., Marktl W., Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995 345 : 1408.
15. Kabuto M., Namura I., Saitoh Y. Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans. Endocrinol Jpn 1986 33 : 405 14.
16. Garfinkel D., Laudon M., Nof D., Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995 346 : 541 4.
17. Garfinkel D., Zisapel N., Wainstein J., Laudon M. Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med 1999 159 : 2456 60.
18. Shamir E., Laudon M., Barak Y., Anis Y., Rotenberg V., Elizur A. et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000 61 : 373 7.
19. Smits M. G., Nagtegaal E. E., van der Heijden J., Coenen A. M., Kerkhof G. A. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol 2001 16 : 86 92.
20. Adelson M. O., Hayward R., Bodner G., Bleich A., Gelkopf M., Kreek M. J. Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. J Maint Addict 2000 1 : 5 13.
21. Peles E., Schreiber S., Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006 82 : 211 17.
22. Hawks R. L. Analytical methodology. NIDA Res Monogr 1986 73 : 30 42.
23. Buysse D. J., Reynolds C. F. III., Monk T. H., Berman S. R., Kupfer D. J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989 28 : 193 213.
24. Radloff L. S. The CES-D Scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1977 1 : 385 401.
25. Buscemi N., Vandermeer B., Hooton N., Pandya R., Tjosvold L., Hartling L. et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 2006 332 : 385 93.
26. Soares C. N. Insomnia in women: an overlooked epidemic? Arch Womens Ment Health 2005 8 : 205 13.
27. Peles E., Schreiber S., Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 2006 82 : 103 10.
28. Hajak G., Rodenbeck A., Bandelow B., Friedrichs S., Huether G., Ruther E. Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects. Eur Neuropsychopharmacol 1996 6 : 149 53.
29. McIntyre I. M., Burrows G. D., Norman T. R. Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol Psychiatry 1988 24 : 108 12.
30. Atsmon J., Oaknin S., Laudon M., Laschiner S., Gavish M., Dagan Y. et al. Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites. J Pineal Res 1996 20 : 65 71.
31. Pandi-Perumal S. R., Srinivasan V., Maestroni G. J., Cardinali D. P., Poeggeler B., Hardeland R. Melatonin. FEBS J 2006 273 : 2813 38.
32. Ebadi M., Govitrapong P., Phansuwan-Pujito P., Nelson F., Reiter R. J. Pineal opioid receptors and analgesic action of melatonin. J Pineal Res 1998 24 : 193 200.
33. Shavali S., Ho B., Govitrapong P., Sawlom S., Ajjimaporn A., Klongpanichapak S. et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005 64 : 471 9.
34. Peles E., Schreiber S., Gordon J., Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 2005 113 : 340 6.
35. Moroz G. High-potency benzodiazepines: recent clinical results. J Clin Psychiatry 2004 65 : 13 18.